ProMIS Neurosciences (NASDAQ:PMN) traded higher on Tuesday after BTIG launched its coverage with a Buy rating and an $8 per share target
https://seekingalpha.com/news/4017851-promis-neuro-stock-draws-buy-btig-alzheimers-asset
ProMIS Neurosciences (NASDAQ:PMN) traded higher on Tuesday after BTIG launched its coverage with a Buy rating and an $8 per share target
https://seekingalpha.com/news/4017851-promis-neuro-stock-draws-buy-btig-alzheimers-asset
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.